Invention Grant
- Patent Title: Truncated HER2 SRM/MRM assay
-
Application No.: US13993045Application Date: 2011-12-08
-
Publication No.: US09765380B2Publication Date: 2017-09-19
- Inventor: David Krizman
- Applicant: David Krizman
- Applicant Address: US MD Rockville
- Assignee: Expression Pathology, Inc.
- Current Assignee: Expression Pathology, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Edell, Shaprio & Finnan, LLC.
- International Application: PCT/US2011/064045 WO 20111208
- International Announcement: WO2012/078934 WO 20120614
- Main IPC: G01N33/74
- IPC: G01N33/74 ; G01N30/72 ; G01N33/48 ; C12Q1/37 ; G01N33/68 ; C07K14/71

Abstract:
This disclosure provides ten (10) specific peptides, and particular peptide characteristics, from the cell membrane-bound Her2 protein and a diagnostic assay useful for determining the presence and amount of full length and truncated versions of the full-length Her2 protein in cells derived from formalin fixed paraffin embedded tissue.
Public/Granted literature
- US20130302328A1 TRUNCATED HER2 SRM/MRM ASSAY Public/Granted day:2013-11-14
Information query
IPC分类: